Related Experiment Video
Updated: Aug 5, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
Peter Calvert1, Dhiraj Gupta1, Gregory Y H Lip1
1Department of Cardiology, Liverpool Centre for Cardiovascular Science and Liverpool Heart & Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool, L14 3PE, UK.
Insights
Atrial fibrillation (AF) is linked to dementia and stroke. Managing AF effectively, using the
Area of Science:
- Neurology and Cardiology: Investigating the intricate relationship between cardiovascular health and cognitive function.
Background:
- Atrial fibrillation (AF) is a known risk factor for cerebrovascular events, including stroke.
- Emerging evidence highlights a significant association between AF and various forms of dementia, such as Alzheimer's disease and vascular dementia.
- Neurocognitive impairment is increasingly recognized as a complication of untreated or poorly managed AF.
Approach:
- This narrative review synthesizes current research on the pathophysiological mechanisms connecting AF and dementia.
- We examine the impact of AF on brain health, including mechanisms like embolism, hemodynamic changes, and systemic inflammation.
- The review discusses the clinical implications and benefits of proactive AF management strategies.
Key Points:
- Effective management of atrial fibrillation is crucial for mitigating the risk of stroke and cognitive decline.
- The 'ABC' pathway (Avoid stroke, Beat symptoms, Control rate/rhythm) provides a guideline-recommended framework for AF management.
- Addressing AF can potentially reduce the incidence and progression of dementia.
Conclusions:
- Optimizing AF treatment according to established guidelines is essential for preserving cognitive function and preventing dementia.
- Integrating cardiovascular care with neurological health strategies is vital for comprehensive patient management.
- Further research into the specific pathways linking AF and dementia may yield novel therapeutic targets.
Abstract:
Atrial fibrillation (AF) has a recognized association with not only stroke, but also neurocognitive impairment and both vascular and Alzheimer's dementia. Effective management of AF can reduce the risk of such complications. In this narrative review article, we discuss the pathophysiological links between AF and dementia, as well as the benefits of adherence to the guideline-recommended 'ABC' pathway.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome I: Introduction

